Effect of Omega-3 fatty acid on patients with coronary heart disease

Phase 3

• Conditions: Coronary Heart Disease.; Chronic ischemic heart disease, unspecified; I25.9

• Registration Number: IRCT2017020412438N22
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Inclusion Criteria: Subjects aged 40-100 years
Patients diagnosed with type 2 diabetes and coronary heart disease

Exclusion Criteria

Exclusion Criteria: Individuals consuming omega-3 supplements within the last 3 months
having an acute myocardial infarction or cardiac surgery within the past 3 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.